Skip to main content
Clinical Trials/IRCT20151226025699N5
IRCT20151226025699N5
Not yet recruiting
Phase 2

The effect of vitamin A, B, C, D, and E supplementations on biochemical parameters of critically ill patients with COVID-19: A randomized clinical trial

Sabzevar University of Medical Sciences0 sites135 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
COVID-19.
Sponsor
Sabzevar University of Medical Sciences
Enrollment
135
Status
Not yet recruiting
Last Updated
5 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
5 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Sabzevar University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • Written consent for participation
  • Age over 34 years
  • A diagnosis of COVID\-19 based on symptoms such as severe pneumonia, fever, fatigue, dry cough, respiratory distress, and lungs involvement in the computed tomographic (CT) scan according to the doctor's confirmation
  • Awareness score of at least 3 based on the 15\-point Glasgow Coma Score (GCS)

Exclusion Criteria

  • Not tendency to participate in the study
  • Diagnosed cardiovascular and lung diseases which can disturb the study process
  • A diagnosis of malignant tumors
  • Recent use of chemotherapy drugs
  • Having incomplete medical records
  • Non\-compliance with the vitamin A, B, C, D, and E supplementations
  • Consumption of vitamin A, B, C, D, and E supplementations during the last 3\-month before the study
  • Pregnancy in women

Outcomes

Primary Outcomes

Not specified

Similar Trials